BioDlink(TOT BIOPHARM) offers cutting-edge ADC/Bioconjugates and
analytical technologies, stands with its robust quality management system and a
GMP-compliant commercial production base. With a validated R&D and
industrialization platform for antibodies, proteins, ADCs, and bioconjugates, BioDlink(TOT BIOPHARM) is a trusted one-stop CDMO partner for ADC/Bioconjugated
drug development.
One-Site Manufacturing for Efficiency
An
integrated ADC commercial production facility consolidates antibodies,
proteins, ADC/Bioconjugates drug substance (DS), and drug product (DP) manufacturing in a single
location, accelerating timelines, optimizing costs, and minimizing risks.
High-Quality Development with
Comprehensive Capabilities
The
extensive ADC/XDC analytical technology platform, equipped with independent
capabilities for critical quality attribute analysis, ensures high-quality
product development.
Expert Full-Process Service Team
A
dedicated team of professionals supports the entire process—from R&D and
process development to regulatory submission, clinical batches, and commercial
production—ensuring smooth project advancement.
